Mr. Shaun Flanagan:

My understanding is that the FDA is fairly inclined to say "yes" to medicines. In relation to Translarna I know it was not its first look by the FDA. In fact, the actual current look by the FDA was an appeal by PTC Therapeutics against a previous refusal to accept an application.